Answers are grounded in this paper and cite their sources.
Adalimumab therapy seems to be an efficacious option for the treatment of children with juvenile rheumatoid arthritis. (ClinicalTrials.gov number, NCT00048542.)
No takes yet. Share an insight, caveat, or question.
Lovell et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: